DiseaseID 930
高钙血症
disease
Autosomal dominant hypocalcemia (AD hypocalcemia) is a disorder of calcium homeostasis characterized by variable degrees of hypocalcemia with abnormally low levels of parathyroid hormone (PTH) and per
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Disease: 1Formula: 12Herb: 12Symptom: 12Target: 24Links: 60
Arranging relationship network...
Record Fields
Scalar fields from the final disease record.
- Disease Id
- 930
- Core Entity Id
- 1051
- Source Entity Count
- 1
- Preferred Name
- Hypercalcemia
- Name Cn
- 高钙血症
- Name Pinyin
- Gao Gai Xue Zheng
- Name En
- Hypercalcemia
- Name Latin
- Bilingual Status
- complete
- Disease Type
- disease
- Umls Disease Type
- Congenital Abnormality
- Disgenet Type
- disease
- Mesh Class
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Endocrine System DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Endocrine System DiseasesEndocrine System DiseasesEndocrine System Diseases; Nutritional and Metabolic Diseases; Pathological Conditions, Signs and SymptomsEndocrine System Diseases; Stomatognathic Diseases; Neoplasms; Musculoskeletal DiseasesNutritional and Metabolic DiseasesPathological Conditions, Signs and Symptoms
- Do Class
- disease of anatomical entitydisease of anatomical entity; genetic diseasedisease of metabolismgenetic disease; disease of anatomical entity; disease of metabolismgenetic disease; disease of metabolism
- Hpo Class
- Abnormality of metabolism/homeostasisAbnormality of the endocrine system
- Mesh Class Name
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Endocrine System DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Endocrine System DiseasesEndocrine System DiseasesNeoplasms; Musculoskeletal Diseases; Endocrine System Diseases; Stomatognathic DiseasesNutritional and Metabolic DiseasesPathological Conditions, Signs and SymptomsPathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases; Endocrine System Diseases
- Hpo Class Name
- Abnormality of metabolism/homeostasisAbnormality of the endocrine system
- Do Class Name
- disease of anatomical entitydisease of metabolismdisease of metabolism; genetic diseasedisease of metabolism; genetic disease; disease of anatomical entitygenetic disease; disease of anatomical entity
- Disease Definition
- Autosomal dominant hypocalcemia (AD hypocalcemia) is a disorder of calcium homeostasis characterized by variable degrees of hypocalcemia with abnormally low levels of parathyroid hormone (PTH) and per
- Version
- v1
- Suppressed
- No
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
Hypercalcemia
Role
preferred
Name
Calcium Metabolism Disorders
Role
preferred
Name
Familial Benign Hypercalcemia
Role
preferred
Name
Familial Isolated Hypoparathyroidism Due To Agenesis Of Parathyroid Gland
Role
preferred
Name
Hyperparathyroidism
Role
preferred
Name
Hyperparathyroidism, Primary
Role
preferred
Name
Hypocalcemia, Autosomal Dominant 1
Role
preferred
Name
Hypocalciuric Hypercalcemia, Familial, Type 1
Role
preferred
Name
Hypocalciuric Hypercalcemia, Familial, Type I
Role
preferred
Name
Hypocalciuric Hypercalcemia, Familial, Type Iii
Role
preferred
Name
Hypoparathyroidism
Role
preferred
Name
Hypoparathyroidism - Autosomal Dominant
Role
preferred
Name
Hypoparathyroidism Familial Isolated
Role
preferred
Name
Hypoparathyroidism, Autosomal Recessive
Role
preferred
Name
Autosomal Dominant Hypocalcemia
Role
preferred
Name
Congenital Absence of Parathyroid Gland
Role
preferred
Name
Familial Hyperparathyroidism
Role
preferred
Name
Familial Isolated Hyperparathyroidism
Role
preferred
Name
HYPERPARATHYROIDISM 1
Role
preferred
Name
HYPERPARATHYROIDISM, NEONATAL SEVERE
Role
preferred
Name
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1, WITH BARTTER SYNDROME
Role
preferred
Name
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II (disorder)
Role
preferred
Name
Hyperparathyroidism-Jaw Tumor Syndrome
Role
preferred
Name
Hypocalciuric Hypercalcemia, Acquired
Role
preferred
Name
Hypoparathyroidism - X-Linked
Role
preferred
Name
Hypoparathyroidism, Familial Isolated
Role
preferred
Name
Hypoparathyroidism, X-Linked
Role
preferred
Name
Idiopathic Hypercalciuria
Role
preferred
Name
Idiopathic Hypoparathyroidism
Role
preferred
Name
Milk-Alkali Syndrome
Role
preferred
Name
Other Hypoparathyroidism
Role
preferred
Name
Parathyroid Adenoma, Familial
Role
preferred
Name
Parathyroid Hyperplasia
Role
preferred
Name
Autosomal Dominant Hypocalcemia 1
Role
alias
Name
Calcium Metabolism Disease
Role
alias
Name
Disorders of Calcium Metabolism
Role
alias
Name
Elevated Blood Parathyroid Hormone Level
Role
alias
Name
Enlarged Parathyroid Glands
Role
alias
Name
FAMILIAL BENIGN HYPERCALCEMIA 1
Role
alias
Name
FAMILIAL BENIGN HYPERCALCEMIA, TYPE III
Role
alias
Name
FBH1
Role
alias
Name
FBH3
Role
alias
Name
FHH1
Role
alias
Name
FIH
Role
alias
Name
Familial Benign Hypercalcemia, Type 3
Role
alias
Name
Familial Benign Hypercalcemia, Type Ii
Role
alias
Name
Familial Hypocalciuric Hypercalcemia
Role
alias
Name
Familial Hypocalciuric Hypercalcemia 1
Role
alias
Name
Familial Hypocalciuric Hypercalcemia 2
Role
alias
Name
Familial Hypocalciuric Hypercalcemia 3
Role
alias
Name
Familial Isolated Hypoparathyroidism
Role
alias
Name
HHC1
Role
alias
Name
HHC3
Role
alias
Name
HYPERCALCEMIA, FAMILIAL BENIGN
Role
alias
Name
HYPERCALCEMIA, FAMILIAL BENIGN, OKLAHOMA TYPE
Role
alias
Name
HYPERCALCEMIA, FAMILIAL BENIGN, TYPE III
Role
alias
Name
HYPERCALCIURIC HYPOCALCEMIA
Role
alias
Name
HYPOC1
Role
alias
Name
HYPOCALCEMIA, FAMILIAL
Role
alias
Name
HYPOPARATHYROIDISM, AUTOSOMAL DOMINANT
Role
alias
Name
High Blood Calcium Levels
Role
alias
Name
Hypercalcaemia
Role
alias
Name
Hypercalcemia, Familial Benign, Type Ii
Role
alias
Name
Hypercalciuric Hypocalcemia, Familial
Role
alias
Name
Hyperparathyroidism 2
Role
alias
Name
Hyperparathyroidism 2 With Jaw Tumors
Role
alias
Name
Hyperparathyroidism, Familial Isolated Primary
Role
alias
Name
Hyperparathyroidism, Neonatal Severe Primary
Role
alias
Name
Hyperparathyroidism, Unspecified
Role
alias
Name
Hypocalciuric Hypercalcemia, Familial, Type 2
Role
alias
Name
Hypocalciuric Hypercalcemia, Familial, Type Ii
Role
alias
Name
Hypoparathyroidism, Unspecified
Role
alias
Name
Increased Calcium In Blood
Role
alias
Name
Low Parathyroid Hormone
Role
alias
Name
Parathyroid Absence
Role
alias
Name
Parathyroid Agenesis
Role
alias
Name
Parathyroid Aplasia
Role
alias
Name
Parathyroid Glands, Agenesis Of
Role
alias
Name
Primary Hyperparathyroidism
Role
alias
Name
X-Linked Hypoparathyroidism
Role
alias
Cross References
Trusted external identifiers retained for this final record.
Hpo
HP:0000829HP:0000843HP:0003072HP:0008200HP:0008208HP:0008211
Herb
HBDIS000423HBDIS001421HBDIS001451HBDIS001494HBDIS001951HBDIS004547HBDIS006676HBDIS006677HBDIS007980HBDIS007981HBDIS008037HBDIS008432HBDIS010035HBDIS013532HBDIS014771HBDIS014985HBDIS015100HBDIS015101HBDIS015172HBDIS015845HBDIS015846HBDIS015847HBDIS015863HBDIS015864HBDIS022139HBDIS025297HBDIS027355HBDIS027397HBDIS028441
Me Sh
D002128D006934D006961D007011D049950
Omim
145000145001145980145981146200239200600740601198
Umls
C0006705C0020437C0020502C0020626C0221002C0342345C0342637C0543800C1704981C1809471C1832615C1832648C1833372C1840334C1840348C3715128C4048195
Icd10
E20E20.0E20.8E20.9E21.0E21.3E83.5E83.50E83.52
Sym Map
SMDE00587SMDE01771SMDE02458SMDE02500SMDE02817SMDE02926SMDE02956SMDE03125SMDE03432SMDE03449SMDE06696SMDE08629SMDE09593SMDE09637SMDE09638SMDE09687SMDE09707SMDE09708SMDE09709SMDE09710
Do Class
DOID:0014667DOID:630DOID:7
Dis Ge Net
C0006705C0020437C0020502C0020626C0026141C0221002C0271844C0271846C0342342C0342344C0342345C0342637C0348454C0543800C1321907C1704981C1809471C1832615C1832648C1833372C1840334C1840347C1840348C1840402C1840403C3715128C4048195C4551961C4552089
Orphanet
219722394174289987999880
Umls Sty
T019T047T191
Hpo Class
HP:0000818HP:0001939
Me Sh Class
C04C05C07C16C18C19C23
Etcm Disease
Familial Isolated Hypoparathyroidism Due to Agenesis of Parathyroid GlandHyperparathyroidism 1Hyperparathyroidism, Neonatal SevereHypocalcemia, Autosomal Dominant 1Hypocalciuric Hypercalcemia, Familial, Type IHypocalciuric Hypercalcemia, Familial, Type IiiHypoparathyroidism, Familial IsolatedHypoparathyroidism, X-LinkedIdiopathic Hypercalciuria
Tcmbank Disease
1028611346128713618158441722617491784618131925219329197052141121505218072259524413259992630126681272413108532167385341986393698392594469469917
Itcmdb Generated
ITX-DISEASE-062D74610411ITX-DISEASE-0D30113A47AAITX-DISEASE-255322F33384ITX-DISEASE-39FD40C2DB84ITX-DISEASE-4207956759BAITX-DISEASE-4ABDB70B3009ITX-DISEASE-4BF90FD2DFBFITX-DISEASE-6ABAEE794D46ITX-DISEASE-6D64E8151E4CITX-DISEASE-72E1B57088D3ITX-DISEASE-84EF8128CA39ITX-DISEASE-906340813821ITX-DISEASE-96F09BE00E66ITX-DISEASE-C704ADE0831FITX-DISEASE-CCFE3AAF3278ITX-DISEASE-D578B45F33D0ITX-DISEASE-D999C0E6D42CITX-DISEASE-FAD673320538
Attributes
Merged source attributes and domain-specific metadata.
Version
v1v1,v2v2
Suppress
0
Page Title
Disease Familial Isolated Hypoparathyroidism Due to Agenesis of Parathyroid Gland Details pageDisease Hyperparathyroidism 1 Details pageDisease Hyperparathyroidism, Neonatal Severe Details pageDisease Hypocalcemia, Autosomal Dominant 1 Details pageDisease Hypocalciuric Hypercalcemia, Familial, Type I Details pageDisease Hypocalciuric Hypercalcemia, Familial, Type Iii Details pageDisease Hypoparathyroidism, Familial Isolated Details pageDisease Hypoparathyroidism, X-Linked Details pageDisease Idiopathic Hypercalciuria Details page
Do Class Name
disease of anatomical entitydisease of metabolismdisease of metabolism; genetic diseasedisease of metabolism; genetic disease; disease of anatomical entitygenetic disease; disease of anatomical entity
Disease Type
diseasegroup
Hpo Class Name
Abnormality of metabolism/homeostasisAbnormality of the endocrine system
Do Disease Class
disease of anatomical entitydisease of anatomical entity; genetic diseasedisease of metabolismgenetic disease; disease of anatomical entity; disease of metabolismgenetic disease; disease of metabolism
Hpo Disease Class
Abnormality of metabolism/homeostasisAbnormality of the endocrine system
Umls Disease Type
Congenital AbnormalityDisease or SyndromeNeoplastic Process
Basic Information
Disease Name
Familial Isolated Hypoparathyroidism Due to Agenesis of Parathyroid Gland
Global Category
Genetic diseases;Rare diseases
Anatomical Category
Endocrine diseases;Eye diseases
Disease Name
Hyperparathyroidism 1
Global Category
Cancer diseases;Genetic diseases;Rare diseases
Anatomical Category
Blood diseases;Bone diseases;Endocrine diseases
Disease Name
Hyperparathyroidism, Neonatal Severe
Global Category
Fetal diseases;Genetic diseases;Metabolic diseases;Rare diseases
Anatomical Category
Bone diseases;Endocrine diseases;Neuronal diseases;Oral diseases
Disease Name
Hypocalcemia, Autosomal Dominant 1
Global Category
Genetic diseases;Metabolic diseases;Rare diseases
Anatomical Category
Endocrine diseases;Eye diseases;Neuronal diseases
Disease Name
Hypocalciuric Hypercalcemia, Familial, Type I
Global Category
Fetal diseases;Genetic diseases;Metabolic diseases;Rare diseases
Anatomical Category
Bone diseases;Endocrine diseases;Immune diseases;Nephrological diseases;Respiratory diseases
Disease Name
Hypocalciuric Hypercalcemia, Familial, Type Iii
Global Category
Fetal diseases;Genetic diseases;Metabolic diseases;Rare diseases
Anatomical Category
Bone diseases;Endocrine diseases;Immune diseases;Nephrological diseases;Respiratory diseases
Disease Name
Hypoparathyroidism, Familial Isolated
Global Category
Genetic diseases;Rare diseases
Anatomical Category
Endocrine diseases;Eye diseases
Disease Name
Hypoparathyroidism, X-Linked
Global Category
Genetic diseases;Rare diseases
Anatomical Category
Endocrine diseases
Disease Name
Idiopathic Hypercalciuria
Global Category
Rare diseases
Anatomical Category
Nephrological diseases
Disease Definition
Autosomal dominant hypocalcemia (AD hypocalcemia) is a disorder of calcium homeostasis characterized by variable degrees of hypocalcemia with abnormally low levels of parathyroid hormone (PTH) and perMSH2017_2016_08_12:Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.NCI2016_02D:An autosomal dominant inherited syndrome characterized by the development of parathyroid adenoma or carcinoma, ossifying fibroma of the mandible and maxilla, renal neoplasms, and renal cysts.NCI2016_NICHD_1602D:A hereditary condition caused by calcium sensing receptor gene mutations, resulting in calcium-hyposensitivity, and compensatory hypercalcemia and hypocalciuria.|NCI2016_02D:A hereditary condition caused by calcium sensing receptor gene mutations, resulting in calcium-hyposensitivity, and compensatory hypercalcemia and hypocalciuria.(NICHD)NCI2016_NICHD_1602D:Abnormally high level of calcium in the blood.|NCI2016_NCI-GLOSS_1602D:Higher than normal levels of calcium in the blood. Some types of cancer increase the risk of hypercalcemia.|NCI2016_CTCAE_1602D:A disorder characterized by laboratory test results that indicate an elevation in the concentration of calcium in blood.|NCI2016_02D:Abnormally high concentration of calcium in the peripheral blood.|MSH2017_2016_08_12:Abnormally high level of calcium in the blood.|HPO2016_07_04:An abnormally increased calcium concentration in the blood. [HPO:curators]|CSP2006:abnormally high level of calcium in the blood; manifestations include fatigability, muscle weakness, depression, anorexia, nausea, and constipation.|CHV2011_02:high level of calcium in the blood|CHV2011_02:high level of calcium in the bloodNCI2016_NICHD_1602D:Abnormally low levels of parathyroid hormone.|NCI2016_CTCAE_1602D:A disorder characterized by a decrease in production of parathyroid hormone by the parathyroid glands.|NCI2016_02D:An endocrine disorder characterized by decreased production of parathyroid hormone by the parathyroid glands. It is usually caused by damage of the parathyroid glands during head and neck surgery. Signs and symptoms include muscle cramps, abdominal pain, dry skin, brittle nails, cataracts, tetany, and convulsions.|MSH2017_2016_08_12:A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.|HPO2016_07_04:A condition caused by a deficiency of parathyroid hormone characterized by hypocalcemia and hyperphosphatemia. [HPO:probinson]|CSP2006:condition produced by greatly reduced function of the parathyroids possibly due to autoimmune disease or genetic factors, or by the removal of those bodies; lack of parathyroid hormone leads to a fall in plasma calcium level, which may result in increase neuromuscular excitability and ultimately tetany followed by a rise in plasma phosphate level.NCI2016_NICHD_1602D:Overproduction of parathyroid hormone due to a disorder originating within the parathyroid glands.|NCI2016_02D:Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones.|MSH2017_2016_08_12:A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.|HPO2016_07_04:A type of hyperparathyroidism caused by a primary abnormality of the parathyroid glands (e.g., adenoma, carcinoma, hyperplasia). Primary hyperparathyroidism is associated with hyercalcemia. [HPO:probinson]NCI2016_NICHD_1602D:Overproduction of parathyroid hormone.|NCI2016_NCI-GLOSS_1602D:A condition in which the parathyroid gland (one of four pea-sized organs found on the thyroid) makes too much parathyroid hormone. This causes a loss of calcium from the bones and an increased level of calcium in the blood. Symptoms include bone pain and kidney problems.|NCI2016_CTCAE_1602D:A disorder characterized by an increase in production of parathyroid hormone by the parathyroid glands. This results in hypercalcemia (abnormally high levels of calcium in the blood).|NCI2016_02D:Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones. Secondary hyperparathyroidism is caused by the chronic stimulation of the parathyroid glands in patients with chronic renal failure, rickets, and malabsorption syndromes.|MSH2017_2016_08_12:A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.|HPO2016_07_04:Excessive production of parathyroid hormone (PTH) by the parathyroid glands. [HPO:probinson]|CSP2006:abnormally increased activity of the parathyroid glands, which may be primary or secondary; primary hyperparathyroidism is associated with neoplasia or hyperplasia; excess of parathyroid hormone leads to alteration in function of bone, renal tubules, and gastrointestinal mucosa.|AIR93:WHAT: Hyperparathyroidism. Hyperparathyroidism: a condition due to an increase in the secretion of the parathyroids, causing generalized osteitis fibrosa cystica, elevated serum calcium, decreased serum phosphorus, and increased excretion of both calcium and phosphorus. WHY: Several rheumatological disorders are associated with hyperpara- thyroidism. First, hyperuricemia and gouty arthritis (which may mimic hyperparathyroidism with renal stone formation and colic) have an increased incidence in patients with hyperparathyroidism. Second, patients with primary hyperparathyroidism show an increased incidence of chondrocalcinosis with episodes of calcium pyrophosphate crystal induced synovitis. Approximately 25% of patients with hyperparathyroidism will show radiographic evidence of calcification of articular cartilage and joint capsules. Finally, there can be a synovial and cartilaginous lesion ("osteogenic synovitis") in patients with hyperparathyroidism which may mimic other primary rheumatic diseases such as rheumatoid arthritis. In osteogenic synovitis there is softening and collapse of subchondral bone. Eventually the cartilage overlying this area erodes and is replaced by an irregular fibrocartilage. Eventually the articular surface of the joint is destroyed and secondary degenerative arthritis may develop. REFS: 1) Zvaifler, NJ; Reefe, WE and Black, RL: Articular manifestations in primary hyperparathyroidism. Arthritis Rheum 5:237, 1962. 2) Scott, JT; Dixon, ASJ and Bywaters, EGL: Association of hyperuricemia and gout with hyperparathyroidism. Br Med J 1:1070, 1964. 3) Bywaters, EGL and Scott, JT : Joint lesions of hyperparathyroidism. Ann Rheum Dis 22:171-87, 1963.SNOMEDCT_US_2016_09_01:Characterized by severe hypercalcemia from birth and associated with major hyperparathyroidism. The prevalence is unknown, clinical manifestations are early and severe including respiratory distress, bone under mineralization and multiple fractures.|SNOMEDCT_US_2016_09_01:Characterised by severe hypercalcaemia from birth and associated with major hyperparathyroidism. The prevalence is unknown, clinical manifestations are early and severe including respiratory distress, bone under mineralisation and multiple fractures.
Me Sh Disease Class
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Endocrine System DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Endocrine System DiseasesEndocrine System DiseasesEndocrine System Diseases; Nutritional and Metabolic Diseases; Pathological Conditions, Signs and SymptomsEndocrine System Diseases; Stomatognathic Diseases; Neoplasms; Musculoskeletal DiseasesNutritional and Metabolic DiseasesPathological Conditions, Signs and Symptoms
Dis Ge Net Disease Type
diseasegroup
Disease Class Name Me Sh
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Endocrine System DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Endocrine System DiseasesEndocrine System DiseasesNeoplasms; Musculoskeletal Diseases; Endocrine System Diseases; Stomatognathic DiseasesNutritional and Metabolic DiseasesPathological Conditions, Signs and SymptomsPathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases; Endocrine System Diseases
Umls Semantic Type Name
Congenital AbnormalityDisease or SyndromeNeoplastic Process